{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:37Z","timestamp":1792783297884,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi dell'Insubria","id":[{"id":"https:\/\/ror.org\/00s409261","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) is an aggressive malignancy defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These molecular characteristics render targeted therapies less effective and contribute to poor clinical outcomes. Towards this, we studied the electroporation-mediated delivery of resveratrol, a polyphenolic compound with pleiotropic anticancer activities, on MDA-MB-231, human TNBC cell line. Both conventional two dimensional (2D) monolayer cell culture and three-dimensional (3D) hyaluronic acid HA-EAbuK-IKVAV scaffold-based cell cultures were used. Two electroporation (EP) protocols (EP1: 8 pulses, 800\u00a0V\/cm, 100 \u00b5s at 1\u00a0Hz; EP2: 8 pulses, 1000\u00a0V\/cm, 100 \u00b5s at 1\u00a0Hz) were evaluated for their effects on cytotoxicity and reactive oxygen species (ROS) generation. In 3D, the combined treatment similarly reduced viability to 20% (EP1\u2009+\u2009Resv) and 17% (EP2\u2009+\u2009Resv), whereas in 2D, the viability reduction is 24% and 18%, respectively. Mechanistically, ROS levels increased substantially with the combination treatment: in 2D, ROS rose to 3 times (EP1\u2009+\u2009Resv) and around 3.5 times (EP2\u2009+\u2009Resv) the control, while in 3D, ROS increased to 2.4 times (EP1\u2009+\u2009Resv) and 2.9 times (EP2\u2009+\u2009Resv). Moreover, the combined treatment of electroporation and resveratrol administration on 3D HA-EAbuK-IKVAV-cultured cells decreased the expression of cell cycle regulatory protein Cdk2 and proliferation marker Ki67. These findings highlight the importance of 3D microenvironmental cues in modulating TNBC responsiveness to resveratrol and underscore the potential of combining electroporation with natural compounds as a rational therapeutic strategy for this challenging subtype of breast cancer.<\/jats:p>","DOI":"10.1007\/s12013-026-02127-8","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:07:42Z","timestamp":1786691262000},"page":"4369-4380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Three-Dimensional Hyaluronic Acid-Based Scaffold Model for Electroporation-Enhanced Resveratrol Therapy in Triple-Negative Breast Cancer"],"prefix":"10.1007","volume":"84","author":[{"given":"Pragatheiswar","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Dettin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annj","family":"Zamuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Conconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio G.","family":"Camarillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Dall\u2019Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-0576","authenticated-orcid":false,"given":"Elisabetta","family":"Sieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raji","family":"Sundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"6797","key":"2127_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M., et al. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747\u2013752. https:\/\/doi.org\/10.1038\/35021093","journal-title":"Nature"},{"issue":"9","key":"2127_CR2","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/j.1349-7006.2009.01228.x","volume":"100","author":"N Yamaguchi","year":"2009","unstructured":"Yamaguchi, N., et al. (2009). Constitutive activation of nuclear factor-\u03baB is preferentially involved in the proliferation of basal\u2010like subtype breast cancer cell lines. Cancer Science, 100(9), 1668\u20131674. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01228.x","journal-title":"Cancer Science"},{"issue":"7","key":"2127_CR3","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann, B. D., et al. (2011). Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. Journal of Clinical Investigation, 121(7), 2750\u20132767. https:\/\/doi.org\/10.1172\/JCI45014","journal-title":"Journal of Clinical Investigation"},{"issue":"20","key":"2127_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes, W. D., et al. (2010). Triple-negative breast cancer. The New England Journal of Medicine, 363(20), 1938\u20131948. https:\/\/doi.org\/10.1056\/NEJMra1001389","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"2127_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini, G., et al. (2016). Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nature Reviews Clinical Oncology, 13(11), 674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"11","key":"2127_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/1078-0432.CCR-10-0939","volume":"13","author":"CK Anders","year":"2010","unstructured":"Anders, C. K., et al. (2010). Poly(ADP-Ribose) Polymerase Inhibition: Targeted Therapy for Triple-Negative Breast Cancer. Clinical Cancer Research, 13(11), 674\u2013690. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0939","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"2127_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","volume":"20","author":"O Gluz","year":"2009","unstructured":"Gluz, O., et al. (2009). Triple-negative breast cancer\u2013current status and future directions. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 20(12), 1913\u20131927. https:\/\/doi.org\/10.1093\/annonc\/mdp492","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"28","key":"2127_CR8","doi-asserted-by":"publisher","first-page":"46652","DOI":"10.18632\/oncotarget.16938","volume":"8","author":"AA Jitariu","year":"2017","unstructured":"Jitariu, A. A., et al. (2017). Triple negative breast cancer: the kiss of death. Oncotarget, 8(28), 46652\u201346662. https:\/\/doi.org\/10.18632\/oncotarget.16938","journal-title":"Oncotarget"},{"key":"2127_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05870.x","volume":"1215","author":"Y Shukla","year":"2011","unstructured":"Shukla, Y., & Singh, R. (2011). Resveratrol and cellular mechanisms of cancer prevention. Annals of the New York Academy of Sciences, 1215, 1\u20138. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05870.x","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"2127_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"Salehi, B., et al. (2018). Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines, 6(3), 91. https:\/\/doi.org\/10.3390\/biomedicines6030091","journal-title":"Biomedicines"},{"key":"2127_CR11","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.2147\/OTT.S259016","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang, H. (2020). Resveratrol Suppresses Tumor Progression via Inhibiting STAT3\/HIF-1\u03b1\/VEGF Pathway in an Orthotopic Rat Model of Non-Small-Cell Lung Cancer (NSCLC). OncoTargets and therapy, 13, 7057\u20137063. https:\/\/doi.org\/10.2147\/OTT.S259016","journal-title":"OncoTargets and therapy"},{"issue":"40","key":"2127_CR12","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1038\/sj.onc.1207630","volume":"23","author":"S Fulda","year":"2004","unstructured":"Fulda, S., & e Debatin, K. M. (2004). Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene, 23(40), 6702\u20136711. https:\/\/doi.org\/10.1038\/sj.onc.1207630","journal-title":"Oncogene"},{"issue":"5A","key":"2127_CR13","first-page":"2783","volume":"24","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal, B. B. (2004). Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research, 24(5A), 2783\u20132840.","journal-title":"Anticancer Research"},{"issue":"11","key":"2127_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00018-022-04551-4","volume":"79","author":"M Behroozaghdam","year":"2022","unstructured":"Behroozaghdam, M., et al. (2022). Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cellular and molecular life sciences: CMLS, 79(11), 539. https:\/\/doi.org\/10.1007\/s00018-022-04551-4","journal-title":"Cellular and molecular life sciences: CMLS"},{"issue":"3","key":"2127_CR15","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1530\/ERC-13-0171","volume":"21","author":"LG Carter","year":"2014","unstructured":"Carter, L. G., et al. (2014). Resveratrol and cancer: focus on in vivo evidence. Endocrine-Related Cancer, 21(3), R209\u2013225. https:\/\/doi.org\/10.1530\/ERC-13-0171","journal-title":"Endocrine-Related Cancer"},{"issue":"4","key":"2127_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson, R., et al. (2014). Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay and Drug Development Technologies, 12(4), 207\u2013218. https:\/\/doi.org\/10.1089\/adt.2014.573","journal-title":"Assay and Drug Development Technologies"},{"issue":"3","key":"2127_CR17","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.3390\/ijms16035517","volume":"16","author":"D Antoni","year":"2015","unstructured":"Antoni, D., et al. (2015). Three-dimensional cell culture: a breakthrough in vivo. International Journal of Molecular Sciences, 16(3), 5517\u20135527. https:\/\/doi.org\/10.3390\/ijms16035517","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"2127_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1087057117696795","volume":"22","author":"Y e Fang","year":"2017","unstructured":"Fang, Y., & e Eglen, R. M. (2017). Three-Dimensional Cell Cultures in Drug Discovery and Development. Slas Discovery, 22(5), 456\u2013472. https:\/\/doi.org\/10.1177\/1087057117696795","journal-title":"Slas Discovery"},{"issue":"10","key":"2127_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth1085","volume":"4","author":"C Fischbach","year":"2007","unstructured":"Fischbach, C., et al. (2007). Engineering tumors with 3D scaffolds. Nature Methods, 4(10), 855\u2013860. https:\/\/doi.org\/10.1038\/nmeth1085","journal-title":"Nature Methods"},{"issue":"9","key":"2127_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/17460441.2012.708334","volume":"7","author":"DV LaBarbera","year":"2012","unstructured":"LaBarbera, D. V., et al. (2012). The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opinion on Drug Discovery, 7(9), 819\u2013883. https:\/\/doi.org\/10.1517\/17460441.2012.708334","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"10","key":"2127_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni, F., et al. (2007). The third dimension bridges the gap between cell culture and live tissue. Nature Reviews Molecular Cell Biology, 8(10), 839\u2013845. https:\/\/doi.org\/10.1038\/nrm2236","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7","key":"2127_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole, B. P. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nature Reviews Cancer, 4(7), 528\u2013539. https:\/\/doi.org\/10.1038\/nrc1391","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"2127_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.semcancer.2008.03.017","volume":"18","author":"R Stern","year":"2008","unstructured":"Stern, R. (2008). Hyaluronidases in cancer biology. Seminars in Cancer Biology, 18(4), 275\u2013280. https:\/\/doi.org\/10.1016\/j.semcancer.2008.03.017","journal-title":"Seminars in Cancer Biology"},{"key":"2127_CR24","doi-asserted-by":"publisher","first-page":"108624","DOI":"10.1016\/j.bioelechem.2023.108624","volume":"156","author":"A Zamuner","year":"2024","unstructured":"Zamuner, A., et al. (2024). Development of 3D melanoma cultures on a hyaluronic acid-based scaffold with synthetic self-assembling peptides: Electroporation enhancement. Bioelectrochemistry, 156, 108624. https:\/\/doi.org\/10.1016\/j.bioelechem.2023.108624","journal-title":"Bioelectrochemistry"},{"issue":"1","key":"2127_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0302-4598(00)00112-4","volume":"53","author":"LM Mir","year":"2001","unstructured":"Mir, L. M. (2001). Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry, 53(1), 1\u201310. https:\/\/doi.org\/10.1016\/S0302-4598(00)00112-4","journal-title":"Bioelectrochemistry"},{"issue":"8","key":"2127_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.tibtech.2015.06.002","volume":"33","author":"T Kotnik","year":"2015","unstructured":"Kotnik, T., et al. (2015). Electroporation-based applications in biotechnology. Trends in Biotechnology, 33(8), 480\u2013488. https:\/\/doi.org\/10.1016\/j.tibtech.2015.06.002","journal-title":"Trends in Biotechnology"},{"issue":"1","key":"2127_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1475-925X-13-29","volume":"13","author":"D Miklav\u010di\u010d","year":"2014","unstructured":"Miklav\u010di\u010d, D., et al. (2014). Electrochemotherapy: from the drawing board into medical practice. Biomedical Engineering Online, 13(1), 29. https:\/\/doi.org\/10.1186\/1475-925X-13-29","journal-title":"Biomedical Engineering Online"},{"issue":"2\u20133","key":"2127_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0304-4165(99)00094-x","volume":"1428","author":"J Gehl","year":"1999","unstructured":"Gehl, J., et al. (1999). In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochimica Et Biophysica Acta, 1428(2\u20133), 233\u2013240. https:\/\/doi.org\/10.1016\/s0304-4165(99)00094-x","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"2","key":"2127_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0169-409X(97)00034-3","volume":"26","author":"MJ Jaroszeski","year":"1997","unstructured":"Jaroszeski, M. J., et al. (1997). Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. Delivery of Chemotherapeutic Drugs, 26(2), 185\u2013197. https:\/\/doi.org\/10.1016\/S0169-409X(97)00034-3","journal-title":"Delivery of Chemotherapeutic Drugs"},{"issue":"1","key":"2127_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejso.2012.08.016","volume":"39","author":"B Mali","year":"2013","unstructured":"Mali, B., et al. (2013). Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. European Journal of Surgical Oncology (EJSO), 39(1), 4\u201316. https:\/\/doi.org\/10.1016\/j.ejso.2012.08.016","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"issue":"5","key":"2127_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.7785\/tcrt.2012.500224","volume":"10","author":"I Edhemovic","year":"2011","unstructured":"Edhemovic, I. (2011). Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technology in cancer research & treatment, 10(5), 475\u2013485.","journal-title":"Technology in cancer research &amp; treatment"},{"issue":"12","key":"2127_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s11517-012-0991-8","volume":"50","author":"D Miklav\u010di\u010d","year":"2012","unstructured":"Miklav\u010di\u010d, D., et al. (2012). Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Medical & Biological Engineering & Computing, 50(12), 1213\u20131225. https:\/\/doi.org\/10.1007\/s11517-012-0991-8","journal-title":"Medical &amp; Biological Engineering &amp; Computing"},{"issue":"1","key":"2127_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2478\/v10019-010-0002-3","volume":"44","author":"D Miklavcic","year":"2010","unstructured":"Miklavcic, D., & Towhidi, L. (2010). Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiology and Oncology, 44(1), 34\u201341. https:\/\/doi.org\/10.2478\/v10019-010-0002-3","journal-title":"Radiology and Oncology"},{"issue":"7","key":"2127_CR34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","volume":"57","author":"J Gehl","year":"2018","unstructured":"Gehl, J., et al. (2018). Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica, 57(7), 874\u2013882. https:\/\/doi.org\/10.1080\/0284186X.2018.1454602","journal-title":"Acta Oncologica"},{"issue":"21","key":"2127_CR35","first-page":"5475","volume":"59","author":"JT Price","year":"1999","unstructured":"Price, J. T. (1999). Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3\u2019-kinase and phospholipase C-dependent mechanism. Cancer Research, 59(21), 5475\u20135478.","journal-title":"Cancer Research"},{"issue":"11","key":"2127_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","volume":"4","author":"M Marty","year":"2006","unstructured":"Marty, M., et al. (2006). Electrochemotherapy \u2013 An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. European Journal of Cancer Supplements, 4(11), 3\u201313. https:\/\/doi.org\/10.1016\/j.ejcsup.2006.08.002","journal-title":"European Journal of Cancer Supplements"},{"key":"2127_CR37","doi-asserted-by":"crossref","unstructured":"Napotnik, T. B. (2016). Fluorescent Indicators of Membrane Permeabilization Due to Electroporation, in Handbook of Electroporation (a c. diMiklavcic, D.), Springer International Publishing, Cham, pp. 1\u201319.","DOI":"10.1007\/978-3-319-26779-1_133-1"},{"key":"2127_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bioelechem.2017.12.005","volume":"120","author":"T e Batista Napotnik","year":"2018","unstructured":"Batista Napotnik, T., & e Miklav\u010di\u010d, D. (2018). vitro electroporation detection methods \u2013 An overview. Bioelectrochemistry, 120, 166\u2013182. https:\/\/doi.org\/10.1016\/j.bioelechem.2017.12.005","journal-title":"Bioelectrochemistry"},{"key":"2127_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2020.107626","author":"E Sieni","year":"2020","unstructured":"Sieni, E., et al. (2020). Breast cancer cells grown on hyaluronic acid-based scaffolds as 3D in vitro model for electroporation. Bioelectrochemistry. https:\/\/doi.org\/10.1016\/j.bioelechem.2020.107626","journal-title":"Bioelectrochemistry"},{"issue":"7","key":"2127_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/095535491820873191","volume":"3","author":"AH Cory","year":"1991","unstructured":"Cory, A. H., et al. (1991). Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture. Cancer Communications, 3(7), 207\u2013212. https:\/\/doi.org\/10.3727\/095535491820873191","journal-title":"Cancer Communications"},{"issue":"11","key":"2127_CR41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0891-5849(03)00142-4","volume":"34","author":"H Zhao","year":"2003","unstructured":"Zhao, H., et al. (2003). Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radical Biology and Medicine, 34(11), 1359\u20131368. https:\/\/doi.org\/10.1016\/S0891-5849(03)00142-4","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"2127_CR42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF01002772","volume":"11","author":"LC Junqueira","year":"1979","unstructured":"Junqueira, L. C., et al. (1979). Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. The Histochemical Journal, 11(4), 447\u2013455. https:\/\/doi.org\/10.1007\/BF01002772","journal-title":"The Histochemical Journal"},{"issue":"8","key":"2127_CR43","doi-asserted-by":"publisher","first-page":"963","DOI":"10.14670\/HH-11-601","volume":"30","author":"M Patruno","year":"2015","unstructured":"Patruno, M. (2015). Might the masson trichrome stain be considered a useful method for categorizing experimental tendon lesions? Histology and Histopathology, 30(8), 963\u2013969. https:\/\/doi.org\/10.14670\/HH-11-601","journal-title":"Histology and Histopathology"},{"issue":"1\/2","key":"2127_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2307\/2333100","volume":"40","author":"H Scheff\u00e9","year":"1953","unstructured":"Scheff\u00e9, H. (1953). A Method for Judging all Contrasts in the Analysis of Variance. Biometrika, 40(1\/2), 87\u2013104. https:\/\/doi.org\/10.2307\/2333100","journal-title":"Biometrika"},{"issue":"2","key":"2127_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2307\/3001913","volume":"5","author":"JW Tukey","year":"1949","unstructured":"Tukey, J. W. (1949). Comparing Individual Means in the Analysis of Variance. Biometrics, 5(2), 99\u2013114. https:\/\/doi.org\/10.2307\/3001913","journal-title":"Biometrics"},{"issue":"10","key":"2127_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.mattod.2015.05.002","volume":"18","author":"W Asghar","year":"2015","unstructured":"Asghar, W., et al. (2015). Engineering cancer microenvironments for in vitro 3-D tumor models. Materials Today, 18(10), 539\u2013553. https:\/\/doi.org\/10.1016\/j.mattod.2015.05.002","journal-title":"Materials Today"},{"key":"2127_CR47","doi-asserted-by":"publisher","unstructured":"Husain, O., et al. (2026). Quantitative Histomorphometric Analysis of Collagen Bundles in Masson\u2019s Trichrome Stained Rat (Rattus norvegicus) Skin: A Methodological Study. Health Science Reports https:\/\/doi.org\/10.1002\/hsr2.71998","DOI":"10.1002\/hsr2.71998"},{"key":"2127_CR48","doi-asserted-by":"publisher","unstructured":"Li, X., et al. (2024). Prognostic significance of collagen content in solitary fibrous tumors of the central nervous system. Frontiers in Oncology 14. https:\/\/doi.org\/10.3389\/fonc.2024.1450813","DOI":"10.3389\/fonc.2024.1450813"},{"issue":"11","key":"2127_CR49","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1109\/TBME.2011.2167232","volume":"58","author":"G Pucihar","year":"2011","unstructured":"Pucihar, G. (2011). Equivalent Pulse Parameters for Electroporation. Biomedical Engineering IEEE Transactions on, 58(11), 3279\u20133288.","journal-title":"Biomedical Engineering IEEE Transactions on"},{"issue":"11","key":"2127_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00018-022-04551-4","volume":"79","author":"M Behroozaghdam","year":"2022","unstructured":"Behroozaghdam, M., et al. (2022). Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cellular and Molecular Life Sciences: CMLS, 79(11), 539. https:\/\/doi.org\/10.1007\/s00018-022-04551-4","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"1","key":"2127_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.137.1.231","volume":"137","author":"VM Weaver","year":"1997","unstructured":"Weaver, V. M., et al. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. The Journal of Cell Biology, 137(1), 231\u2013245. https:\/\/doi.org\/10.1083\/jcb.137.1.231","journal-title":"The Journal of Cell Biology"},{"issue":"14","key":"2127_CR52","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2174\/138945012804545632","volume":"13","author":"D Sinha","year":"2012","unstructured":"Sinha, D., et al. (2012). Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Current Drug Targets, 13(14), 1799\u20131819. https:\/\/doi.org\/10.2174\/138945012804545632","journal-title":"Current Drug Targets"},{"issue":"4","key":"2127_CR53","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1109\/TPS.2008.2000996","volume":"36","author":"S Corovic","year":"2008","unstructured":"Corovic, S. (2008). Numerical Modeling and Optimization of Electric Field Distribution in Subcutaneous Tumor Treated With Electrochemotherapy Using Needle Electrodes. Plasma Science IEEE Transactions on, 36(4), 1665\u20131672.","journal-title":"Plasma Science IEEE Transactions on"},{"key":"2127_CR54","doi-asserted-by":"publisher","unstructured":"Polaj\u017eer, T. E., & Miklav\u010di\u010d, D. (2023). Immunogenic Cell Death in Electroporation-Based Therapies Depends on Pulse Waveform Characteristics. Vaccines, 11(6). https:\/\/doi.org\/10.3390\/vaccines11061036","DOI":"10.3390\/vaccines11061036"},{"key":"2127_CR55","doi-asserted-by":"publisher","first-page":"811726","DOI":"10.3389\/fimmu.2021.811726","volume":"12","author":"N Zhang","year":"2021","unstructured":"Zhang, N., et al. (2021). Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors. Frontiers in Immunology, 12, 811726. https:\/\/doi.org\/10.3389\/fimmu.2021.811726","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2127_CR56","doi-asserted-by":"publisher","first-page":"9702","DOI":"10.1038\/s41467-025-65785-x","volume":"16","author":"AS Yadav","year":"2025","unstructured":"Yadav, A. S., et al. (2025). Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy. Nature Communications, 16(1), 9702. https:\/\/doi.org\/10.1038\/s41467-025-65785-x","journal-title":"Nature Communications"},{"key":"2127_CR57","doi-asserted-by":"publisher","unstructured":"Vallin, J. R. Cellular fragmentation underlies the immunogenicity of irreversible electroporation-mediated tumor cell killing. Bioengineering & Translational Medicine https:\/\/doi.org\/10.1002\/btm2.70102","DOI":"10.1002\/btm2.70102"},{"issue":"2","key":"2127_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10555-016-9615-3","volume":"35","author":"CY Calvet","year":"2016","unstructured":"Calvet, C. Y., & e Mir, L. M. (2016). The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Reviews, 35(2), 165\u2013177. https:\/\/doi.org\/10.1007\/s10555-016-9615-3","journal-title":"Cancer Metastasis Reviews"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02127-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:16:02Z","timestamp":1789632962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02127-8","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"17 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}